Skip to content
10-Q

Quarterly Report

LIPOSCIENCE INC

0001168197-14-000034

← back to feed
Filed
May 15, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · May 8, 2014 15.24M sh
Capex Q1 2014 · Mar 31, 2014 $1.83M
Capex Q1 2014 · Mar 31, 2013 $1.22M
Cash And Equivalents Q1 2014 · Mar 31, 2014 $45.05M
Cash And Equivalents Q1 2014 · Dec 31, 2013 $49.57M
Cash And Equivalents Q1 2014 · Mar 31, 2013 $55.05M
Cash And Equivalents Q1 2014 · Dec 31, 2012 $24.77M
Stockholders Equity Q1 2014 · Mar 31, 2014 $46.11M
Stockholders Equity Q1 2014 · Dec 31, 2013 $47.76M
Current Liabilities Q1 2014 · Mar 31, 2014 $20.68M
Current Liabilities Q1 2014 · Dec 31, 2013 $21.61M
Total Liabilities Q1 2014 · Mar 31, 2014 $23.29M
Total Liabilities Q1 2014 · Dec 31, 2013 $24.24M
Current Assets Q1 2014 · Mar 31, 2014 $52.58M
Current Assets Q1 2014 · Dec 31, 2013 $56.59M
Total Assets Q1 2014 · Mar 31, 2014 $69.4M
Total Assets Q1 2014 · Dec 31, 2013 $72M
Sga Expense Q1 2014 · Mar 31, 2014 $3.35M
Sga Expense Q1 2014 · Mar 31, 2013 $3.31M
Rd Expense Q1 2014 · Mar 31, 2014 $2.56M
Rd Expense Q1 2014 · Mar 31, 2013 $3.13M
Net Income Q1 2014 · Mar 31, 2014 −$2.04M
Net Income Q1 2014 · Mar 31, 2013 −$2.85M
Operating Income Q1 2014 · Mar 31, 2014 −$1.61M
Operating Income Q1 2014 · Mar 31, 2013 −$2.33M
Gross Profit Q1 2014 · Mar 31, 2014 $9.39M
Gross Profit Q1 2014 · Mar 31, 2013 $10.77M